Literature DB >> 382082

Intravenous linoleic acid supplementation in children with cystic fibrosis.

H P Chase, E K Cotton, R B Elliott.   

Abstract

Ten children with CF in matched pairs were infused with either Intralipid or with 10% glucose on a double blind basis every other week for one year. Although statistically there was significantly greater gain in height and weight in the study year compared to the previous year only for the test group, both groups improved more than expected. Cumulative data analysis showed greater improvement for the Intralipid group (23 of a possible 45 points) compared to the glucose group (-2 points; P less than .02). This study indicates the need to better define the role of nutrition in the pathophysiology of CF. Meanwhile, it is recommended that all children with CF have plasma linoleic acid levels measured at least once yearly, and if levels are low, appropriate supplements should be given.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 382082

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 2.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

3.  A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.

Authors:  S D Freedman; M H Katz; E M Parker; M Laposata; M Y Urman; J G Alvarez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.

Authors:  G N Thompson
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

5.  Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; J Felipe Garcia-Espana; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

6.  Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  V Rogiers; A Vercruysse; I Dab; D Baran
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

Review 7.  Cystic fibrosis.

Authors:  M R Bye; J M Ewig; L M Quittell
Journal:  Lung       Date:  1994       Impact factor: 2.584

Review 8.  Human milk in disease: lipid composition.

Authors:  M Hamosh; J Bitman
Journal:  Lipids       Date:  1992-11       Impact factor: 1.880

9.  Absorption of triglycerides with defined or random structure by rats with biliary and pancreatic diversion.

Authors:  M S Christensen; A Müllertz; C E Høy
Journal:  Lipids       Date:  1995-06       Impact factor: 1.880

Review 10.  Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?

Authors:  Birgitta Strandvik
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.